Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
VRTXVertex Pharmaceuticals | $117.92bn | 29.64 | n/a |
REGNRegeneron Pharmaceuticals | $108.53bn | 28.09 | n/a |
MRNAModerna | $63.85bn | n/a | n/a |
SGENSeagen | $43.15bn | n/a | n/a |
IQVIqvia Holdings | $41.83bn | 29.81 | n/a |
ICLRIcon | $26.52bn | 35.46 | n/a |
BNTXBioNTech SE | $23.05bn | 178.08 | n/a |
ALNYAlnylam Pharmaceuticals | $18.69bn | n/a | n/a |
NBIXNeurocrine Biosciences | $14.03bn | 37.91 | n/a |
TECHBIO-TECHNE | $12.73bn | 60.15 | 0.4% |
KRTXKaruna Therapeutics | $12.58bn | n/a | n/a |
UTHRUnited Therapeutics | $12.10bn | 12.88 | n/a |
MEDPMedpace Holdings | $12.10bn | 39.8 | n/a |
SRPTSarepta Therapeutics | $11.67bn | n/a | n/a |
CRLCharles River Laboratories International | $11.19bn | 23.26 | n/a |
QGENQiagen NV | $9.70bn | 26.25 | n/a |
RXDXPrometheus Biosciences | $9.56bn | n/a | n/a |
EXASExact Sciences | $9.20bn | n/a | n/a |
IMGNImmunoGen | $8.72bn | n/a | n/a |
ASNDAscendis Pharma A/S | $7.59bn | n/a | n/a |